Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancerC Manegold, B Bergman, A Chemaissani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2011
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancerC Manegold, N van Zandwijk, A Szczesna, et al.
Lung Cancer (Amsterdam, Netherlands)|November 24, 1999
Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancerW W ten Bokkel Huinink, B Bergman, A Chemaissani, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2004
Induction treatment before surgery for non-small cell lung cancerW E Eberhardt, K S Albain, H Pass, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomesT Le Chevalier, G Scagliotti, R Natale, et al.
Neurology|May 28, 2010
Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiencyL Brun, L H Ngu, W T Keng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 8, 2021
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancerS Novello, V Torri, C Grohe, et al.
Pageof 18